Skip to content

GAIN THERAPEUTICS, INC

GANX

CIK 0001819411

← back to feed
Revenue (TTM)
$203.79K
−58.4% YoY Q1 Apr 2026
Net Income (TTM)
−$21.23M
+1.2% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$0.63
+31.5% YoY Q1 Apr 2026
Gross Margin
—
Q1 Apr 2026
Operating Margin
-9,616.8%
Q1 Apr 2026
Net Margin
-10,418.6%
Q1 Apr 2026
Free Cash Flow (TTM)
−$16.45M
Q1 Apr 2026
Cash
$16.54M
Q1 Apr 2026
Total Debt
$373.55K
Q1 Apr 2026
Shares Outstanding
42.65M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings